235
Views
7
CrossRef citations to date
0
Altmetric
Letter to the Editor

L-carnitine does not ameliorate asparaginase-associated hepatotoxicity in a C57BL6 mouse model

, , &
Pages 2088-2090 | Received 13 Sep 2018, Accepted 09 Jan 2019, Published online: 04 Feb 2019
 

Disclosure statement

Dr. Relling receives investigator-initiated support from Shire Pharmaceuticals for clinical asparaginase studies.

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at https://doi.org/10.1080/10428194.2019.1571198.

Additional information

Funding

This research was supported by National Cancer Institute [R01 CA 142665].

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.